Does the amount of an antitumor agent entrapped in liposomes influence its tissue distribution and cell uptake?
- 25 September 1998
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 131 (2) , 163-170
- https://doi.org/10.1016/s0304-3835(98)00145-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.Journal of Clinical Oncology, 1995
- Determination of the Thickness of the Fixed Aqueous Layer Around Polyethyleneglycol-coated LiposomesJournal of Drug Targeting, 1995
- Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behaviorBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Free and Liposomal Doxorubicin Treatment of Intraperitoneal Colon 26 Tumor: Therapeutic and Pharmacologic StudiesSelective Cancer Therapeutics, 1990
- Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administrationEuropean Journal of Clinical Pharmacology, 1986
- Analysis of adriamycin and adriamycinol in micro volumes of rat plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Determination of adriamycin (doxorubicin) and related fluorescent compounds in rat lymph and gall by high-performance liquid chromatographyJournal of Chromatography A, 1981
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- AdriamycinAnnals of Internal Medicine, 1974